A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

NCT06258265 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-279
DRUG: TAK-279 Placebo
DRUG: Moxifloxacin
DRUG: Moxifloxacin Placebo

Sponsor

Takeda